Perspectives on Enquiry & Evidence
FDA Increases Calls for Manufacturers to Ensure Trial Diversity, but Does It Fall Short of Addressing Health Inequalities in Product Development?
The evidence is staggering on the unequal health burdens experienced by specific patient groups defined by ethnic, gender, or socioeconomic risk factors and the different health outcomes these groups may have in clinical trials. And while efforts have been made to address these inequalities, they are still falling short.
Top Interviews of 2022: Industry Voices and Career Perspectives
Career Perspectives: A Conversation with Veronica Chan
Career Perspectives: A Conversation with Malte Stein
Career Perspectives: A Conversation with Nicolas Rouillé
Interview with Allison Luccock about career perspectives
Career Perspectives: Reflecting at 10 Years in Cytel FSP
Career Perspectives: Interview with Charles Warne, Associate Director of Biostatistics
Career Perspectives: Interview with Jessica Bhoyroo, Clinical Data Manager
Career Perspectives: Interview with Alyssa Biller, Senior Solutions Consultant
Career Perspectives: Interview with Anil Golla, Vice President, FSP
Career Perspectives: Interview with Sam Hsiao, Associate Director, Strategic Consulting
Subscribe to our weekly newsletter
By submitting you agree to Cytel’s Privacy Notice